» Articles » PMID: 39654789

The Role of Neutrophil Extracellular Traps in Crohn's Disease

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Dec 10
PMID 39654789
Authors
Affiliations
Soon will be listed here.
Abstract

Crohn's disease (CD) is an idiopathic and chronic inflammation of the gastrointestinal (GI) tract. The underlying pathogenesis of CD is multifaceted, with complex interactions between genetic predisposition, environmental triggers, and abnormalities within the immune system. Neutrophil extracellular traps (NETs) have gained significant attention as a novel component in the pathogenesis of CD. NETs are intricate structures fashioned from DNA, histones, and granule proteins, and are actively released by neutrophils to entangle and eliminate pathogenic microbes. This review article delves into the intricate role of NETs in the pathogenesis of CD. We examine how NETs may serve as a pivotal mechanism for the recruitment of immune cells to the site of inflammation. NETs are known to influence the function of epithelial cells, which line the GI tract, potentially contributing to the structural integrity and barrier dysfunction observed in CD. NETs stimulate inflammation, a hallmark of the disease, by releasing pro-inflammatory molecules and activating immune cells. We also investigate the promising therapeutic potential of targeting NETs in CD. By intercepting the formation or function of NETs, it may be possible to mitigate the chronic inflammation, reduce tissue damage, and alleviate the symptoms associated with CD. Strategies to inhibit NET formation, such as the use of DNase I and approaches to disrupt NET-mediated signaling pathways, are discussed in CD therapeutics. Understanding the detailed mechanisms of NETs is crucial for the development of targeted treatments that could potentially revolutionize the management of CD.

Citing Articles

Changes in tumor and cardiac metabolism upon immune checkpoint.

Leven A, Wagner N, Nienaber S, Messiha D, Tasdogan A, Ugurel S Basic Res Cardiol. 2024; 120(1):133-152.

PMID: 39658699 PMC: 11790718. DOI: 10.1007/s00395-024-01092-8.

References
1.
Drury B, Hardisty G, Gray R, Ho G . Neutrophil Extracellular Traps in Inflammatory Bowel Disease: Pathogenic Mechanisms and Clinical Translation. Cell Mol Gastroenterol Hepatol. 2021; 12(1):321-333. PMC: 8166923. DOI: 10.1016/j.jcmgh.2021.03.002. View

2.
Shang B, Cui H, Xie R, Wu J, Shi H, Bi X . Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target. Biomark Res. 2023; 11(1):24. PMC: 9977644. DOI: 10.1186/s40364-023-00463-y. View

3.
Santacroce G, Lenti M, Di Sabatino A . Therapeutic Targeting of Intestinal Fibrosis in Crohn's Disease. Cells. 2022; 11(3). PMC: 8834168. DOI: 10.3390/cells11030429. View

4.
Aldabbous L, Abdul-Salam V, Mckinnon T, Duluc L, Pepke-Zaba J, Southwood M . Neutrophil Extracellular Traps Promote Angiogenesis: Evidence From Vascular Pathology in Pulmonary Hypertension. Arterioscler Thromb Vasc Biol. 2016; 36(10):2078-87. DOI: 10.1161/ATVBAHA.116.307634. View

5.
Lloyd-Price J, Arze C, Ananthakrishnan A, Schirmer M, Avila-Pacheco J, Poon T . Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019; 569(7758):655-662. PMC: 6650278. DOI: 10.1038/s41586-019-1237-9. View